Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025


Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the fourth quarter and full year of 2024 on February 20, 2025, after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

The link to the live call will be available on the Investor Relations section of the Company's website at investors.insulet.com, "Events and Presentations," and will be archived for future replay. You may also access the live call by dialing (888) 770-7129 for domestic callers, or (929) 203-2109 for international callers, passcode is 5904836.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, visit Insulet.com or omnipod.com.

©2025 Insulet Corporation. Omnipod is a registered trademark of Insulet Corporation. All rights reserved.

Source: Insulet Corporation


These press releases may also interest you

at 09:05
Omeros Corporation today announced the availability on its website of materials accompanying two presentations given at the 2025 Tandem Meetings ? the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and...

at 09:05
Zuora, Inc., a leading monetization platform for modern business, today announced the completion of its acquisition by Silver Lake, the global leader in technology investing, in partnership with an affiliate of GIC Pte. Ltd. ("GIC"), for $10.00 per...

at 09:05
Weave , a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced an integration with Practice Fusion, a leading cloud-based Electronic Health Records (EHR) software for...

at 09:04
InComm Payments, a global payments technology provider, has teamed up with Mastercard to introduce the Mastercard "Give Hope" Gift Cards supporting the American Red Cross. For every purchase of a "Give Hope" gift card on www.mastercardgiftcard.com,...

at 09:00
A new survey from Binance, the global blockchain ecosystem behind the world's largest cryptocurrency exchange by trading volume and users, suggests that most crypto investors take a long-term approach to both investing and romantic relationships....

at 09:00
Triller is making a powerful comeback by teaming up with NBA All-Star Baron Davis' Business Inside the Game (BIG) and influencer organization, REACH, for an exciting presence at NBA All-Star Weekend. BIG, known for its summits, workshops, and...



News published on and distributed by: